![Michelle Williams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michelle Williams
Fondatore presso ELUTIA INC.
Patrimonio netto: 55 575 $ in data 31/05/2024
Profilo
Michelle LeRoux Williams is the founder of Elutia, Inc. which was founded in 2015.
She holds the title of Chief Scientific Officer at Elutia, Inc. Dr. Williams's current job(s) include being a Member at the American Institute For Medical & Biological Engineering and a Member at the California Institute for Regenerative Medicine.
Dr. Williams's former job(s) include being the Chief Scientific Officer at Osiris Therapeutics, Inc. from 2009 to 2014 and the Chief Operating Officer at KeraLink International, Inc. Dr. Williams's education history includes a doctorate degree from Duke University and an undergraduate degree from Rice University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ELUTIA INC CLASS A
0.09% | 10/06/2024 | 17 100 ( 0.09% ) | 55 575 $ | 31/05/2024 |
Posizioni attive di Michelle Williams
Società | Posizione | Inizio |
---|---|---|
ELUTIA INC. | Fondatore | 06/08/2015 |
American Institute For Medical & Biological Engineering
![]() American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Corporate Officer/Principal | - |
California Institute for Regenerative Medicine | Corporate Officer/Principal | - |
Precedenti posizioni note di Michelle Williams
Società | Posizione | Fine |
---|---|---|
OSIRIS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 15/04/2014 |
KeraLink International, Inc.
![]() KeraLink International, Inc. Medical/Nursing ServicesHealth Services KeraLink International, Inc. operates as a non-governmental network of eye and tissue banks. It also provides ocular tissues used in transplant surgeries. The company was founded in 1962 and is headquartered in Baltimore, MD. | Direttore operativo | - |
Formazione di Michelle Williams
Rice University | Undergraduate Degree |
Duke University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ELUTIA INC. | Health Technology |
Aziende private | 4 |
---|---|
Osiris Therapeutics, Inc.
![]() Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
American Institute For Medical & Biological Engineering
![]() American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Commercial Services |
KeraLink International, Inc.
![]() KeraLink International, Inc. Medical/Nursing ServicesHealth Services KeraLink International, Inc. operates as a non-governmental network of eye and tissue banks. It also provides ocular tissues used in transplant surgeries. The company was founded in 1962 and is headquartered in Baltimore, MD. | Health Services |
California Institute for Regenerative Medicine | Government |
- Borsa valori
- Insiders
- Michelle Williams